-
-
-
-
-
-
-
This U.S. biotech stock is Bernstein's Top Pick for 2026
-
-
-
-
-
-
-
HSBC Upgrades Abbvie (ABBV) to Buy
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $242 at Guggenheim, 'Looking for Additional Treats on Halloween to Drive Further Upside'
-
-
-
-
-
-
-
AbbVie Reports Second-Quarter 2025 Financial Results
-
-
-
-
-
-
-
HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
-
-
-
-
-
-
-
AbbVie (ABBV) issues updated guidance
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $227 as Piper Sandler 'Likes the Chances for Upside'
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

